Customizing poly(lactic-co-glycolic acid) particles for biomedical applications

被引：229
作者：
Swider, Edyta [1 ]
Koshkina, Olga [1 ]
Tel, Jurjen [1 ,4 ]
Cruz, Luis J. [2 ]
de Vries, I. Jolanda M. [1 ,3 ]
Srinivas, Mangala [1 ]
机构：
[1] Radboud Inst Mol Life Sci, Dept Tumor Immunol, Nijmegen, Netherlands
[2] Leiden Univ, Med Ctr, Dept Radiol, Leiden, Netherlands
[3] Radboud, Dept Med Oncol, Nijmegen, Netherlands
[4] Eindhoven Univ Technol, Lab Immunoengn, Dept Biomed Engn, Eindhoven, Netherlands
来源：
ACTA BIOMATERIALIA | 2018年 / 73卷
基金：
欧洲研究理事会;
关键词：
Poly(lactic-co-glycolic acid); Particles; Drug delivery; Theranostics; Imaging; PLGA-BASED NANOPARTICLES; CO-GLYCOLIC ACID; DRUG-DELIVERY; DENDRITIC CELLS; BIODEGRADABLE NANOPARTICLES; POLYMERIC NANOPARTICLES; PEG NANOPARTICLES; IN-VITRO; POLY(LACTIDE-CO-GLYCOLIDE); MICROPARTICLES;
D O I：
10.1016/j.actbio.2018.04.006
中图分类号：
R318 [生物医学工程];
学科分类号：
0831 ;
摘要：
Nano- and microparticles have increasingly widespread applications in nanomedicine, ranging from drug delivery to imaging. Poly(lactic-co-glycolic acid) (PLGA) particles are the most widely-applied type of particles due to their biocompatibility and biodegradability. Here, we discuss the preparation of PLGA particles, and various modifications to tailor particles for applications in biological systems. We highlight new preparation approaches, including microfluidics and PRINT method, and modifications of PLGA particles resulting in novel or responsive properties, such as Janus or upconversion particles. Finally, we describe how the preparation methods can- and should-be adapted to tailor the properties of particles for the desired biomedical application. Our aim is to enable researchers who work with PLGA particles to better appreciate the effects of the selected preparation procedure on the final properties of the particles and its biological implications. (C) 2018 Acta Materialia Inc. Published by Elsevier Ltd.
引用
收藏
页码：38 / 51
页数：14
相关论文
共 143 条
  • [11] Development and characterization of protein-loaded poly(lactide-co-glycolide) nanospheres
    Blanco, MD
    Alonso, MJ
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 1997, 43 (03) : 287 - 294
  • [12] Nanoparticle-Based Medicines: A Review of FDA-Approved Materials and Clinical Trials to Date
    Bobo, Daniel
    Robinson, Kye J.
    Islam, Jiaul
    Thurecht, Kristofer J.
    Corrie, Simon R.
    [J]. PHARMACEUTICAL RESEARCH, 2016, 33 (10) : 2373 - 2387
  • [13] Fabrication of asymmetric "Janus'' particles via plasma polymerization
    Chen, Rodney T.
    Muir, Benjamin W.
    Such, Georgina K.
    Postma, Almar
    McLean, Keith M.
    Caruso, Frank
    [J]. CHEMICAL COMMUNICATIONS, 2010, 46 (28) : 5121 - 5123
  • [14] Cancer Cell Membrane-Biomimetic Nanoparticles for Homologous-Targeting Dual-Modal Imaging and Photothermal Therapy
    Chen, Ze
    Zhao, Pengfei
    Luo, Zhenyu
    Zheng, Mingbin
    Tian, Hao
    Gong, Ping
    Gao, Guanhui
    Pan, Hong
    Liu, Lanlan
    Ma, Aiqing
    Cui, Haodong
    Ma, Yifan
    Cai, Lintao
    [J]. ACS NANO, 2016, 10 (11) : 10049 - 10057
  • [15] Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery
    Cheng, Jianjun
    Teply, Benjamin A.
    Sherifi, Ines
    Sung, Josephine
    Luther, Gaurav
    Gu, Frank X.
    Levy-Nissenbaum, Etgar
    Radovic-Moreno, Aleksandar F.
    Langer, Robert
    Farokhzad, Omid C.
    [J]. BIOMATERIALS, 2007, 28 (05) : 869 - 876
  • [16] Size-controlled biodegradable nanoparticles: Preparation and size-dependent cellular uptake and tumor cell growth inhibition
    Choi, Jin-Seok
    Cao, Jiafu
    Naeem, Muhammad
    Noh, Jinki
    Hasan, Nurhasni
    Choi, Hoo-Kyun
    Yoo, Jin-Wook
    [J]. COLLOIDS AND SURFACES B-BIOINTERFACES, 2014, 122 : 545 - 551
  • [17] The Poisson distribution and beyond: methods for microfluidic droplet production and single cell encapsulation
    Collins, David J.
    Neild, Adrian
    deMello, Andrew
    Liu, Ai-Qun
    Ai, Ye
    [J]. LAB ON A CHIP, 2015, 15 (17) : 3439 - 3459
  • [18] Polysorbate 80 in medical products and nonimmunologic anaphylactoid reactions
    Coors, EA
    Seybold, H
    Merk, HF
    Mahler, V
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2005, 95 (06) : 593 - 599
  • [19] Tracking Targeted Bimodal Nanovaccines: Immune Responses and Routing in Cells, Tissue, and Whole Organism
    Cruz, Luis J.
    Tacken, Paul J.
    Zeelenberg, Ingrid S.
    Srinivas, Mangala
    Bonetto, Fernando
    Weigelin, Bettina
    Eich, Christina
    de Vries, I. Jolanda
    Figdor, Carl G.
    [J]. MOLECULAR PHARMACEUTICS, 2014, 11 (12) : 4299 - 4313
  • [20] TARGETING NANOPARTICLES TO DENDRITIC CELLS FOR IMMUNOTHERAPY
    Cruz, Luis J.
    Tacken, Paul J.
    Rueda, Felix
    Carles Domingo, Joan
    Albericio, Fernando
    Figdor, Carl G.
    [J]. NANOMEDICINE: INFECTIOUS DISEASES, IMMUNOTHERAPY, DIAGNOSTICS, ANTIFIBROTICS, TOXICOLOGY AND GENE MEDICINE, 2012, 509 : 143 - 163
12345678910